We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Resveratrol as sensitizer in colorectal cancer plasticity.
- Authors
Brockmueller, Aranka; Sajeev, Anjana; Koklesova, Lenka; Samuel, Samson Mathews; Kubatka, Peter; Büsselberg, Dietrich; Kunnumakkara, Ajaikumar B.; Shakibaei, Mehdi
- Abstract
Despite tremendous medical treatment successes, colorectal cancer (CRC) remains a leading cause of cancer deaths worldwide. Chemotherapy as monotherapy can lead to significant side effects and chemoresistance that can be linked to several resistance-activating biological processes, including an increase in inflammation, cellular plasticity, multidrug resistance (MDR), inhibition of the sentinel gene p53, and apoptosis. As a consequence, tumor cells can escape the effectiveness of chemotherapeutic agents. This underscores the need for cross-target therapeutic approaches that are not only pharmacologically safe but also modulate multiple potent signaling pathways and sensitize cancer cells to overcome resistance to standard drugs. In recent years, scientists have been searching for natural compounds that can be used as chemosensitizers in addition to conventional medications for the synergistic treatment of CRC. Resveratrol, a natural polyphenolic phytoalexin found in various fruits and vegetables such as peanuts, berries, and red grapes, is one of the most effective natural chemopreventive agents. Abundant in vitro and in vivo studies have shown that resveratrol, in interaction with standard drugs, is an effective chemosensitizer for CRC cells to chemotherapeutic agents and thus prevents drug resistance by modulating multiple pathways, including transcription factors, epithelial-to-mesenchymal transition-plasticity, proliferation, metastasis, angiogenesis, cell cycle, and apoptosis. The ability of resveratrol to modify multiple subcellular pathways that may suppress cancer cell plasticity and reversal of chemoresistance are critical parameters for understanding its anti-cancer effects. In this review, we focus on the chemosensitizing properties of resveratrol in CRC and, thus, its potential importance as an additive to ongoing treatments.
- Subjects
COLORECTAL cancer; RESVERATROL; MULTIDRUG resistance; P53 antioncogene; DRUG resistance; TRANSCRIPTION factors
- Publication
Cancer & Metastasis Reviews, 2024, Vol 43, Issue 1, p55
- ISSN
0167-7659
- Publication type
Article
- DOI
10.1007/s10555-023-10126-x